Pregnanetriolone in paper-borne urine for neonatal screening for 21-hydroxylase deficiency: The place of urine in neonatal screening
The standard method of primary neonatal screening for congenital adrenal hyperlasia (CAH), determination of 17-hydroxyprogesterone (17OHP) in heelprick blood, is the object of recurrent controversy because of its poor diagnostic and economic efficiency. The superior ability of urinary pregnanetriolo...
Main Author: | José Ramón Alonso-Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426916300672 |
Similar Items
-
CAH Newborn Screening in India: Challenges and Opportunities
by: Aashima Dabas, et al.
Published: (2020-08-01) -
Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
by: Rūta Navardauskaitė, et al.
Published: (2021-09-01) -
Devastating salt‐wasting crisis in a four‐month‐old male child with congenital adrenal hyperplasia, highlighting the essence of neonatal screening
by: Nagaspurthy Anugu Reddy, et al.
Published: (2022-07-01) -
Newborn Screening in Pediatric Endocrine Disorders
by: Martin Draznin, et al.
Published: (2022-03-01) -
Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
by: Rosa Maria Paragliola, et al.
Published: (2022-07-01)